Similarly, a greater proportion of CD14++ CD16− IL1β+ monocytes were detected in COVID-19 patients by RNA sequencing, which found expression in CD14++ monocytes of pro and anti-inflammatory genes were up and down-regulated, respectively when compared to HCs (68). This evidence concerns the gene IL1B and COVID-19.